<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    electroCore, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About electroCore, Inc.

    electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The company’s current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $426,000,000
    • SIC CODE
      3845
    • NIN CODE
      ####
    • LEADERSHIP
      Francis R. Amato
    • FOUNDED
      2005
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    TFF Pharmaceuticals, Inc.

    TFF Pharmaceuticals, Inc.

    Although intended for the lungs, many drugs are not given via the airway because d...

    Although intended for the lungs, many drugs are...

    Filing Type:    PU
    CashMD

    CashMD

    CashMD, a startup founded in 2017, brings patients and healthcare providers toget...

    CashMD, a startup founded in 2017, brings pati...

    Filing Type:    PR
    Virtuoso Surgical, Inc.

    Virtuoso Surgical, Inc.

    Virtuoso Surgical, Inc. was born out of a collaborative research effort developing...

    Virtuoso Surgical, Inc. was born out of a colla...

    Filing Type:    RA
    Axcella Health Inc.

    Axcella Health Inc.

    Axcella is designing and developing AXA Candidates, compositions of endogenous met...

    Axcella is designing and developing AXA Candida...

    Filing Type:    PU
    Intersect ENT, Inc.

    Intersect ENT, Inc.

    Intersect ENT (NASDAQ: XENT) is a medical technology company dedicated to advancin...

    Intersect ENT (NASDAQ: XENT) is a medical techn...

    Filing Type:    PU
    Mesoblast Limited

    Mesoblast Limited

    Mesoblast Limited (Nasdaq: MESO; ASX:MSB) is a world leader in developing allogene...

    Mesoblast Limited (Nasdaq: MESO; ASX:MSB) is a ...

    Filing Type:    PU
    NeuroMetrix, Inc.

    NeuroMetrix, Inc.

    Founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and ...

    Founded in 1996 as a spinoff from the Harvard-M...

    Filing Type:    PU
    Collegium Pharmaceutical, Inc.

    Collegium Pharmaceutical, Inc.

    Collegium Pharmaceutical is a specialty pharmaceutical company committed to being ...

    Collegium Pharmaceutical is a specialty pharmac...

    Filing Type:    PU
    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc. is a clinical stage biotechnology company developing oral ...

    Evelo Biosciences, Inc. is a clinical stage bio...

    Filing Type:    PU
    BioDelivery Sciences International, Inc.

    BioDelivery Sciences International, Inc.

    BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a rapidly growing comme...

    BioDelivery Sciences International, Inc. (NASDA...

    Filing Type:    PU
    CymaBay Therapeutics Inc.

    CymaBay Therapeutics Inc.

    We are a clinical-stage biopharmaceutical company focused on developing and provid...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.